Home › Targets › STAT6

STAT6 (2 companies · 3 programs)

Companies with an active program directed at STAT6.

Kymera Therapeutics, Inc. KYMR

KT-621 — Atopic Dermatitis Phase 2
KT-621 — Asthma Phase 2

ENANTA PHARMACEUTICALS INC ENTA

EPS-3903 — Atopic Dermatitis Preclinical